Revolutionizing Cell and Gene Therapy Trials with Human-Centered Design and Real Patient Narratives

Greg Christie, Chief Product Officer, StudyKIK

Greg Christie is a renowned thought leader in human-centered product development and design. As the Chief Product Officer at StudyKIK, he has gained recognition for his contributions to clinical research technology. Greg’s work on the oncology app concept earned StudyKIK the SCOPE Participant Engagement Award, emphasizing his commitment to a collaborative and user-focused approach that prioritizes participant experience in cell and gene therapy trials.

Under Greg’s leadership, StudyKIK was selected as a finalist for the esteemed Prix Galien UK 2023 Award in the ‘Best Digital Health Solution’ category. This distinction celebrates the patient-centric design and transformative impact of StudyKIK’s study companion applications across various therapeutic areas, including immunology and women’s health.

Greg recently received the prestigious 2023 PM360 ELITE 100 Award in the Tech-Know Geek category for his contributions in reshaping the medtech landscape through innovative and patient-centric products.

Guiding StudyKIK’s Product and Design teams, Greg brings a wealth of experience from his previous roles at technology organizations such as Goldstar Events, Evite and prominent publications including Elle, Woman’s Day, Car and Driver, Road & Track and Popular Photography. His expertise spans product development, design, branding and marketing, positioning him as a versatile and influential leader in the field.

Jane Bentley, Vice President, Oncology Therapeutic Strategy and Innovation, Syneos Health

In her role as an Innovation and Strategy lead for Oncology at Syneos Health, Jane Bentley leads the Syneos Health Oncology initiatives in advanced cell therapy, including CAR T therapies in collaboration with GRYT Health and the development of a new patient ad board solution (CRAFTT Express) for Oncology Biotech customers. Jane is an active participant in Syneos Health’s cross functional consortia for patient voice, cell and gene therapy and rare disease. She has over 30 years of global oncology clinical research expertise in pharma/CRO, including 20 years leadership experience in oncology global trial management across Phases I-IV. Before joining Syneos Health Jane held oncology leadership roles in several global CROs and consultancy organizations. Her experience in global trial management includes key oncology/hemato-oncology indications (breast cancer melanoma, glioblastoma, prostate cancer, multiple myeloma, AML, supportive care neutropenia/anemia) including immunotherapies and biologicals and across Phases I-IV. Her experience also includes global leadership of registration programs and support of clients in the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) inspection readiness.

She is currently a member of the board at the Institute of Clinical Research and previously held the post of Hon. Lecturer in Clinical Research at Liverpool John Moores University. Jane holds a BSc in pharmacology and a PhD in toxicology from the University of London. She is currently close to completing her study towards an MBA in International Health Medicine.

Joel Santos Gonzalez, Intensive Reading Teacher, Wendell Krinn Technical High School

At 34 years old, Joel Santos Gonzalez is a two-time cancer survivor. He had Hodgkin Lymphoma from 2017-2019 and again from 2020-2021. Joel is presently in remission. As a cancer survivor, he cares a lot about helping others deal with cancer and doing what he can to give back. He is an Intensive Reading Teacher at Wendell Krinn Technical High School.